Sign in

You're signed outSign in or to get full access.

Albert Hanser

Research Analyst at Kestrel Investment Management Corp.

Albert Hanser is Managing Partner at Kestrel Merchant Partners, specializing in emerging growth and special situations equity with a focus on both public and private small-cap companies. With over 25 years of experience, he has led coverage of high-potential early-stage firms and managed investments through Kestrel’s Flight Fund, earning a reputation for navigating transitional periods in portfolio companies. Hanser began his career at Piper Jaffray and in the LIFFE pits, then held roles at Alex. Brown & Sons/Deutsche Bank, spent nine years at ThinkEquity Partners as Managing Director of institutional sales, and seven years as Managing Director of investment banking at Craig-Hallum Capital Group before founding Kestrel in 2019. He holds a B.A. from Brown University and has served on advisory boards, demonstrating both sector expertise and leadership in the investment community.

Albert Hanser's questions to SANUWAVE Health (SNWV) leadership

Question · Q2 2025

Albert Hanser asked for more detail on the value and scope of SANUWAVE's intellectual property portfolio, referencing the 140 patents mentioned in the company's investor presentation, and sought to understand the foundational strength this IP provides.

Answer

CEO Morgan Frank described the extensive patent portfolio as core protection for the company's Shockwave and ultrasound technologies. He mentioned that SANUWAVE has monetized patents in the past, citing the $2.5 million option agreement with Fast Your Wave LLC. While confirming the company regularly evaluates its IP for licensing or sale opportunities, he stated he could not provide further concrete details at this time.

Ask follow-up questions

Fintool

Fintool can predict SANUWAVE Health logo SNWV's earnings beat/miss a week before the call

Question · Q1 2025

Albert Hanser asked for an update on the company's debt situation and potential refinancing opportunities, and also inquired about any upcoming investor conferences or roadshows on the calendar.

Answer

CEO Morgan Frank acknowledged that the company's current debt is expensive and confirmed they are actively exploring refinancing opportunities, expressing optimism about improving the interest rate. He also stated that while they are considering future conference participation, nothing is definitively scheduled yet.

Ask follow-up questions

Fintool

Fintool can write a report on SANUWAVE Health logo SNWV's next earnings in your company's style and formatting